News
The FDA has approved Sephience for the treatment of HPA in adult and pediatric patients 1 month of age and older with sepiapterin-responsive PKU.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback